Precision Genome Engineering
joint with Emerging Cellular Therapies
Scientific Organizers: Jacob E. Corn, Kathy K. Niakan and Cecilia Cotta-Ramusino
Date: February 13 - 17, 2022
Location: Fairmont Chateau Whistler, Whistler, BC, Canada
For important information on the coronavirus, please click here
Precision genome engineering has completely revolutionized biological research and is making inroads to therapies. Progress is rapid, and meetings are a primary way to keep abreast of the field. This meeting will focus pon new fundamental CRISPR-Cas biology, creation of new genome engineering tools (both CRISPR-Cas and otherwise), provide updates on new biological applications, and provide updates on applications moving towards the market such as therapies and agricultural developments. The Keystone CRISPR meeting has been a benchmark of the field and draws large audiences. The continued development of creative new tools and further progress towards real-world application will be a big attraction. Workshops and panels on ethical questions will enrich the scientific program. Joint meeting with cell therapies is ideal, as genome engineering has become de rigeur in this arena. The joint meeting in 2019 was extremely successful. Genome engineer attendees will benefit by learning pain points and missing pieces in the field of cellular therapy, and cell therapy attendees will benefit by hearing about the latest and greatest coming at break-neck speed from the genome engineering field.
Scholarship Deadline: November 2 2021 details
Keystone Symposia is committed to maintaining a positive and respectful environment at its meetings. To this end, please review and comply with our policies
Registered attendees of one meeting in a joint pair may participate in sessions of the other, pending space availability.